Table 3:
EMS positive | EMS negative | P value | |
---|---|---|---|
Self-reported dry mouth, % (n) | 59.4% (19) | 58.3% (7) | 0.25 |
DE symptoms, mean (SD) | |||
Years with DE symptoms | 11.5 (12.5) | 10.0 (11.8) | 0.74 |
DEQ5 (0–22) | 16.3 (3.2) | 16.1 (2.3) | 0.81 |
OSDI (0–100) | 59.7 (21.2) | 57.6 (18.3) | 0.80 |
Pain intensity (0–10) 1 week recall | 5.8 (3.0) | 5.3 (2.8) | 0.70 |
Burning (0–10) | 5.0 (3.2) | 5.4 (4.4) | 0.83 |
Sensitivity to wind (0–10) | 5.2 (3.1) | 5.3 (3.4) | 0.98 |
Sensitivity to light (0–10) | 6.4 (2.9) | 5.5 (3.5) | 0.53 |
DE signs, mean (SD) | |||
Inflammadry* (range 0–3) | 1.1 (0.1) | 1.5 (0.7) | 0.21 |
TBUT* (seconds) | 4.2 (2.6) | 5.7 (4.6) | 0.36 |
Conjunctivochalasis* (range 0–3) | 0.4 (0.4) | 0.3 (0.6) | 0.61 |
Corneal staining* (range 0–15) | 5.3 (4.3) | 4.2 (3.6) | 0.43 |
Persistent pain after anesthesia (range 0–10) | 2.0 (2.3) | 1.9 (2.8) | 0.91 |
Schirmer score at 5 min* (mm) | 5.0 (4.0) | 6.5 (5.6) | 0.45 |
Topical medications†, % (n) | |||
Artificial tears | 100.0% (32) | 83.3% (10) | 0.07 |
Cyclosporine | 100.0% (32) | 75.0% (9) | 0.02 |
Lifitegrast | 40.6% (13) | 8.3% (1) | 0.07 |
Ketotifen | 18.8% (6) | 8.3% (1) | 0.65 |
All dry eye signs represent score in the more severely affected eye.
Current or prior
EMS=Early Markers of Sjögren’s; SD=standard deviation; DE=dry eye; DEQ5=Dry Eye Questionnaire 5; OSDI=Ocular Surface Disease Index; TBUT=tear break up time